The use of noninvasive brain stimulation techniques in autism spectrum disorder
Autism Research · 2024
DOI: 10.1002/aur.3041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Autism Research, 2024. Verfasst von Lindsay M Oberman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Noninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of H…. Hauptthemen laut MEDLINE: Transcranial Direct Current Stimulation, Major Depressive Disorder, Autism Spectrum Disorder. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Noninvasive brain stimulation (NIBS) techniques, including repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), have recently emerged as alternative, nonpharmacological interventions for a variety of psychiatric, neurological, and neurodevelopmental conditions. NIBS is beginning to be applied in both research and clinical settings for the treatment of core and associated symptoms of autism spectrum disorder (ASD) including social communication deficits, restricted and repetitive behaviors, irritability, hyperactivity, depression and impairments in executive functioning and sensorimotor integration. Though there is much promise for these targeted device‐based interventions, in other disorders (including adult major depressive disorder (MDD) and obsessive compulsive disorder (OCD) where rTMS is FDA cleared), data on the safety and efficacy of these interventions in individuals with ASD is limited especially in younger children when neurodevelopmental interventions typically begin. Most studies are open‐label, small scale, and/or focused on a restricted subgroup of individuals with ASD. There is a need for larger, randomized controlled trials that incorporate neuroimaging in order to develop predictive biomarkers of treatment response and optimize treatment parameters. We contend that until such studies are conducted, we do not have adequate estimates of the safety and efficacy of NIBS interventions in children across the spectrum. Thus, broad off‐label use of these techniques in this population is not supported by currently available evidence. Here we discuss the existing data on the use of NIBS to treat symptoms related to ASD and discuss future directions for the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Noninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Lindsay M Oberman, Sunday M Francis, Sarah H Lisanby
Förderung
- Intramural NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Oberman, L. M., Francis, S. M., & Lisanby, S. H. (2024). The use of noninvasive brain stimulation techniques in autism spectrum disorder. Autism Research. https://doi.org/10.1002/aur.3041
Vancouver
Oberman LM, Francis SM, Lisanby SH. The use of noninvasive brain stimulation techniques in autism spectrum disorder. Autism Research. 2024. doi:10.1002/aur.3041
BibTeX
@article{Oberman2024,
author = {Oberman, Lindsay M and Francis, Sunday M and Lisanby, Sarah H},
title = {The use of noninvasive brain stimulation techniques in autism spectrum disorder},
journal = {Autism Research},
year = {2024},
doi = {10.1002/aur.3041}
}
EUVIMED